NN 3901
Alternative Names: NN-3901Latest Information Update: 21 Feb 2022
At a glance
- Originator Novelty Nobility
- Class Drug conjugates; Monoclonal antibodies; Skin disorder therapies
- Mechanism of Action Proto-oncogene protein c-kit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Systemic mastocytosis
Most Recent Events
- 18 Feb 2022 Early research in Systemic mastocytosis in South Korea (unspecified route) (Novelty Nobility pipeline, February 2022)